Background
Methods
Patients and study design
Assessments
Results
Disposition and demographics
Low-risk PV (n = 1033) | High-risk PV (n = 1823) | All patients (N = 2856) | |
---|---|---|---|
Mean (SD) age, years | 49.7 (8.6) | 69.7 (9.9) | 62.5 (13.5) |
Age group, n (%), years | |||
18–34 | 73 (7.1) | 5 (0.3) | 78 (2.7) |
35–54 | 573 (55.5) | 86 (4.7) | 659 (23.1) |
55–64 | 387 (37.5) | 522 (28.6) | 909 (31.8) |
≥ 65 | NA | 1210 (66.4) | 1210 (42.4) |
Sex, n (%) | |||
Male | 757 (73.3) | 1125 (61.7) | 1882 (65.9) |
Female | 276 (26.7) | 698 (38.3) | 974 (34.1) |
Geographic region, n (%) | |||
South | 402 (38.9) | 558 (30.6) | 960 (33.6) |
North Central | 230 (22.3) | 499 (27.4) | 729 (25.5) |
Northeast | 218 (21.1) | 482 (26.4) | 700 (24.5) |
West | 169 (16.4) | 270 (14.8) | 439 (15.4) |
Unknown | 14 (1.4) | 14 (0.8) | 28 (1.0) |
Insurance payer, n (%) | |||
Commercial | 1033 (100) | 613 (33.6) | 1646 (57.6) |
Medicare | 0 | 1210 (66.4) | 1210 (42.4) |
Insurance plan type, n (%) | |||
PPO | 669 (64.8) | 943 (51.7) | 1612 (56.4) |
Comprehensive | 47 (4.5) | 576 (31.6) | 623 (21.8) |
HMO | 106 (10.3) | 150 (8.2) | 256 (9.0) |
POS | 83 (8.0) | 70 (3.8) | 153 (5.4) |
CDHP | 72 (7.0) | 37 (2.0) | 109 (3.8) |
HDHP | 32 (3.1) | 13 (0.7) | 45 (1.6) |
EPO | 6 (0.6) | 18 (1.0) | 24 (0.8) |
POS with capitation | 7 (0.7) | 2 (0.1) | 9 (0.3) |
Unknown | 11 (1.1) | 14 (0.8) | 25 (0.9) |
Clinical characteristics
Low-risk PV (n = 1033) | High-risk PV (n = 1823) | All patients (N = 2856) | |
---|---|---|---|
Comorbid condition, n (%) | |||
Hypertension | 445 (43.1) | 1185 (65.0) | 1630 (57.1) |
Chronic pain | 187 (18.1) | 473 (25.9) | 660 (23.1) |
Diabetes (type 2) | 104 (10.1) | 396 (21.7) | 500 (17.5) |
Osteoarthritis | 102 (9.9) | 366 (20.1) | 468 (16.4) |
Cancer (excluding leukemia and MM) | 66 (6.4) | 381 (20.9) | 447 (15.7) |
Gastroesophageal reflux disease | 121 (11.7) | 224 (12.3) | 345 (12.1) |
Anemia | 64 (6.2) | 168 (9.2) | 232 (8.1) |
Depression | 81 (7.8) | 123 (6.7) | 204 (7.1) |
Anxiety | 73 (7.1) | 117 (6.4) | 190 (6.7) |
Congestive heart failure | 6 (0.6) | 121 (6.6) | 127 (4.4) |
Non-AML leukemia | 5 (0.5) | 14 (0.8) | 19 (0.7) |
MM | 1 (0.1) | 8 (0.4) | 9 (0.3) |
Concomitant medication, n (%) | |||
Cardiovasculara | 636 (61.6) | 1526 (83.7) | 2162 (75.7) |
Corticosteroid (oral or IV) | 306 (29.6) | 510 (28.0) | 816 (28.6) |
Antidepressant | 228 (22.1) | 369 (20.2) | 597 (20.9) |
NSAID | 205 (19.8) | 314 (17.2) | 519 (18.2) |